| Literature DB >> 35897097 |
Jinyou Wang1, Zhouting Tuo1, Mingzhu Gao2, Jie Min1, Yi Wang1, Tao Zhang1, Dexin Yu1, Liangkuan Bi3.
Abstract
BACKGROUND: The need for the left ureter to pass through the subsigmoid during ileal conduit diversion surgery has not been investigated in any studies. A modified technique is simply used in the ileal conduit with the left ureter straight over the sigmoid colon due to the possible damage and lack of scientifically validated advantages of this procedure. Our study aimed to investigate the feasibility of the suggested surgical technique, as well as to evaluate perioperative outcomes and postoperative complications with a focus on the prevalence of small bowel obstruction (SBO) and ureteroileal anastomotic stricture (UAS).Entities:
Keywords: Bowel obstruction; Complications; Ileal conduit; Radical cystectomy; Ureteroileal anastomotic stricture
Mesh:
Year: 2022 PMID: 35897097 PMCID: PMC9330641 DOI: 10.1186/s12894-022-01073-w
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.090
Fig. 1A In our technique, the left ureter (red arrow) passes to the right side over the surface of the sigmoid colon (blue arrow) without establishing a retrosigmoid tunnel, the purple arrow points to the ureteroileal anastomosis. B The ileum (white arrow) was finally covered over the left ureter, and the bowel was carefully checked to avoid a visible internal hernia
Demographic and preoperative characteristics of the 84 patients included in the comparative analysis stratified by transposition of the left ureter in ileal conduit diversion
| Variable | Total cases | Study group (n = 30) | Control group (n = 54) | |
|---|---|---|---|---|
| Age, [years, mean ± SD] | 69.31 ± 9.36 | 70.84 ± 9.89 | 68.44 ± 9.03 | 0.258 |
| Male gender, n (%) | 64 (76.20) | 26 (86.67) | 38 (70.37) | 0.158 |
| ECOG performance status, n (%) | 0.783 | |||
| 0–1 | 79 (94.05) | 28 (93.33) | 51 (94.44) | |
| > 1 | 5 (5.95) | 2 (6.67) | 3 (5.56) | |
| Diabetes mellitus, n (%) | 14 (16.67) | 5 (16.67) | 9 (16.67) | 1.000 |
| BMI, [kg/m2, mean ± SD] | 22.77 ± 3.03 | 22.36 ± 3.04 | 23.00 ± 3.03 | 0.359 |
| ASA score, [cases (%)] | 0.471 | |||
| ≤ 2 | 60 (71.43) | 20 (66.67) | 40 (74.07) | |
| > 2 | 24 (28.57) | 10 (33.33) | 14 (25.93) | |
| Previous abdominal surgery, n (%) | 19 (22.62) | 10 (33.33) | 9 (16.67) | 0.080 |
| Preoperative hydronephrosis, n (%) | 0.399 | |||
| Absent | 71 (84.52) | 24 (80.00) | 47 (87.04) | |
| Unilateral | 7 (8.33) | 3 (10.00) | 4 (7.41) | |
| Bilateral | 6 (7.14) | 3 (10.00) | 3 (5.56) | |
| Clinical tumor stage, n (%) | 0.609 | |||
| ≤ T1 | 28 (33.33) | 8 (26.67) | 20 (37.04) | |
| T2 | 32 (38.10) | 13 (43.33) | 19 (35.19) | |
| T3-4 | 24 (28.57) | 9 (30.00) | 15 (22.22) | |
| Preoperative creatinine, [μmol/L, median (range)] | 80 (49–143.5) | 84 (39–143.5) | 78 (44–135) | 0.307 |
ECOG = Eastern Cooperative Oncology Group; BMI = Body mass index; SD = standard deviation
Operative and pathological characteristics of 84 bladder cancer patients who underwent ileal conduit urinary diversion
| Variable | Total cases | Study group (n = 30) | Control group (n = 54) | |
|---|---|---|---|---|
| Operative time, [min, mean ± SD] | 276.62 ± 41.45 | 271.3 ± 24.03 | 279.57 ± 48.47 | 0.299 |
| EBL, [mL, median (range)] | 80 (30–300) | 65 (40–300) | 90 (30–300) | 0.352 |
| Pathologic T stage, [n (%)] | 0.166 | |||
| T1 | 30 (35.71) | 6 (20.00) | 24 (44.44) | |
| T2 | 32 (38.10) | 14 (46.67) | 18 (33.33) | |
| T3 | 18 (21.43) | 8 (26.67) | 10 (18.52) | |
| T4 | 4 (4.76) | 2 (6.67) | 2 (3.70) | |
| Pathological lymph node invasion, n (%) | 9 (10.71) | 4 (13.33) | 5 (9.26) | 0.563 |
| Postoperative creatinine, [umol/L, median (range)] | 78 (32–179) | 81 (38–158) | 76 (32–179) | 0.501 |
EBL indicates estimated blood loss; SD = standard deviation
Overall 90-days postoperative complications in the 84 patients were included in the comparative analysis
| Complication type | Total cases | Study group (n = 30) | Control group (n = 54) | |
|---|---|---|---|---|
| Bowel obstruction, [n (%)] | 6 (7.14) | 2 (6.67) | 4 (7.41) | 0.899 |
| Reoperation, [n (%)] | 2 (2.38) | 1 (3.33) | 1 (1.85) | 0.670 |
| Febrile urinary tract infection, [n (%)] | 11 (13.10) | 5 (16.67) | 6 (11.11) | 0.470 |
| Wound infection, [n (%)] | 5 (5.95) | 2 (6.67) | 3 (5.56) | 0.837 |
| Wound dehiscence, [n (%)] | 2 (2.38) | 1 (3.33) | 1 (1.85) | 0.670 |
| Vein thrombosis, [n (%)] | 2 (2.38) | 1 (3.33) | 1 (1.85) | 0.670 |
| Sepsis, [n (%)] | 2 (2.38) | 1 (3.33) | 1 (1.85) | 0.670 |
| parastomal hernia, [n (%)] | 1 (1.19) | 0 (0.00) | 1 (1.85) | |
| postoperative hydronephrosis, [n (%)] | 0.857 | |||
| Absent | 43 (51.19) | 16 (53.33) | 27 (50.00) | |
| Unilateral | 15 (17.86) | 5 (16.67) | 10 (18.52) | |
| Bilateral | 26 (30.95) | 9 (30.00) | 17 (31.48) | |
| Hydronephrosis grade, n (%) | 0.873 | |||
| Grade 0 | 43 (51.19) | 16 (53.33) | 27 (50.00) | |
| Grade 1 | 10 (11.90) | 3 (10.00) | 7 (12.86) | |
| Grade 2 | 20 (23.81) | 8 (26.67) | 12 (22.22) | |
| Grade 3 | 11 (13.10) | 3 (10.00) | 8 (14.81) | |
| Grade 4 | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| 90-Days mortality | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Clavien-Dindo classification (< 90d), [n (%)] | 0.431 | |||
| I–II | 24 (28.57) | 10 (33.33) | 14 (25.93) | |
| ≥ III | 5 (5.95) | 2 (6.67) | 3 (5.56) |